Sign inJoin waitlistJoin the waitlist

CC

Cynthia Campen

Program Director, Child Neurology Residency · Stanford Health Care

Credentials: · · · · ·

History

Child Neurology Residency · Stanford Health Care
Present
Stanford Children's Neurofibromatosis Clinic
Present
Stanford University
2023–Present

Child and Adolescent Psychiatry
2012–2014
Lucile Salter Packard Children's Hospital at Stanford
2011–2012
Child Neurology
Stanford University
2009–2011
Child Neurology
Children's Hospital of Philadelphia
2007–2009
University of California, San Francisco
2004–2007
University of California, San Francisco School of Medicine
2000–2004
University of California, Davis
1996–2000

Research

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents
Annals of Neurology · 2009 · 787 citations
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
Nature · 2022 · 697 citations
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Nature · 2025 · 172 citations

Kristen Yeom
10 papers
Gerald Grant
9 papers
Paul Fisher
9 papers
Laura Prolo
8 papers
Sonia Partap
8 papers
Michelle Monje
7 papers
Crystal Mackall
5 papers
Jasia Mahdi
5 papers · 4 as a fellow
Kara Davis
5 papers · 1 as a resident
Robbie Majzner
5 papers
Sneha Ramakrishna
5 papers
JM
Jen Moon
4 papers

Clinical trials

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Site PI · Recruiting · Phase 2
University of Alabama at Birmingham
2025–2032
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Site PI · Recruiting · Phase 2
Healx Limited
2025–2028
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
Sub-investigator · Recruiting · Phase 1
Stanford University
2020–2043